Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating fatty liver

A composition, fatty liver technology, applied in the directions of pharmaceutical formulations, medical preparations containing active ingredients, pill delivery, etc., can solve the problem of not finding a completely satisfactory treatment plan, etc., and achieve no toxic side effects, short course of treatment, and low price. Effect

Inactive Publication Date: 2017-02-22
郑州莉迪亚医药科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, for the treatment of fatty liver, neither traditional Chinese medicine nor Western medicine has found a completely satisfactory treatment plan

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] A pharmaceutical composition for treating fatty liver, the main raw materials in parts by weight are: 8 parts of L-glutamine, 0.2 part of D-tryptophan, 4 parts of allicin, 0.2 part of geraniin, glucuronolactone 10 parts, 3 parts of corilagin, 0.9 parts of dendrobine, 0.2 parts of danshensu sodium, 4 parts of ethyl p-methoxycinnamate, and 1 part of silymarin.

[0017] A preparation method of a pharmaceutical composition for treating fatty liver, the specific steps are:

[0018] First, in a pharmaceutical-grade clean area, weigh L-glutamine, D-tryptophan, allicin, geranidin, glucuronolactone, corilagin, dendrobine, and danshensu sodium according to the above metering ratio , ethyl p-methoxycinnamate, silymarin, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, controlled RSD≤5%, after mixing, pressed into tablets and dried at low temperature, the temperature was controlled at 10 DEG C, pack and obtain the pharmaceutical ...

Embodiment 2

[0020] A pharmaceutical composition for treating fatty liver, the main raw materials in parts by weight are: 11 parts of L-glutamine, 0.4 parts of D-tryptophan, 5 parts of allicin, 0.3 parts of geraniin, glucuronolactone 12 parts, 4 parts of corilagin, 1.2 parts of dendrobine, 0.2 parts of danshensu sodium, 4 parts of ethyl p-methoxycinnamate, and 1 part of silymarin.

[0021] A preparation method of a pharmaceutical composition for treating fatty liver, the specific steps are:

[0022] First, in a pharmaceutical-grade clean area, weigh L-glutamine, D-tryptophan, allicin, geranidin, glucuronolactone, corilagin, dendrobine, and danshensu sodium according to the above metering ratio , ethyl p-methoxycinnamate, silymarin, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4min, controlled RSD≤5%, after mixing, pressed into tablets and dried at low temperature, the temperature was controlled at 10 DEG C, pack and obtain the pharmaceutic...

Embodiment 3

[0024] A pharmaceutical composition for treating fatty liver, the main raw materials in parts by weight are: 14 parts of L-glutamine, 0.5 part of D-tryptophan, 6 parts of allicin, 0.5 part of geraniin, glucuronolactone 15 parts, 5 parts of corilagin, 1.3 parts of dendrobine, 0.4 parts of danshensu sodium, 5 parts of ethyl p-methoxycinnamate, and 2 parts of silymarin.

[0025] A preparation method of a pharmaceutical composition for treating fatty liver, the specific steps are:

[0026] First, in a pharmaceutical-grade clean area, weigh L-glutamine, D-tryptophan, allicin, geranidin, glucuronolactone, corilagin, dendrobine, and danshensu sodium according to the above metering ratio , ethyl p-methoxycinnamate, silymarin, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 6 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature, the temperature was controlled at 10 DEG C, pack and obtain the pharma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition for treating fatty liver. The medicinal composition for treating the fatty liver comprises, by weight, 6-22 parts of L-glutamine, 0.2-0.6 part of D-tryptophan, 2-10 parts of allicin, 0.2-0.7 part of geraniin, 10-20 parts of glucurolactone, 3-7 parts of Corilagin, 0.9-1.5 parts of dendrobine, 0.2-0.5 part of salvianic acid A sodium, 4-6 parts of P-methoxyl methyl cinnamate and 1-3 parts of silymarin. The medicinal composition improves symptoms and signs of patients with fatty livers remarkably, can regulate blood lipid metabolism obviously, has the advantages of good curative effect, short treatment course, low price, non-existence of toxic and side effects on the whole and the like, and has promotion and application value in fatty liver treatment.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a pharmaceutical composition for treating fatty liver. Background technique [0002] Under normal circumstances, fat accounts for 3% to 5% of the total weight of the liver. Fatty liver occurs when the fat content exceeds 1 / 10 of the liver weight or more than half of the liver cells become fatty. Its pathogenesis has not been fully clarified so far. It is generally believed that the imbalance between the synthesis of triacylglycerol and the secretion of very low-density lipoprotein in liver cells is the main cause of fatty liver, and this imbalance is due to the increase of fat synthesis or oxidation in liver cells. caused by the reduction. With the change of living habits and diet structure, the enhancement of health care awareness, and the improvement of detection methods, the incidence and detection rate of fatty liver have gradually increased, and it has become a common h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K9/20A61K31/192A61K31/198A61K31/216A61K31/255A61K31/357A61K31/405A61K31/407A61K31/7024
CPCA61K31/198A61K9/2004A61K31/192A61K31/216A61K31/255A61K31/357A61K31/405A61K31/407A61K31/7024A61K31/7048A61K2300/00
Inventor 不公告发明人
Owner 郑州莉迪亚医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com